CA1303986C - Action anti-proliferative des arn double brin sur les tumeurs
- Google Patents
Action anti-proliferative des arn double brin sur les tumeurs
Info
Publication number
CA1303986C
CA1303986CCA 486814CA486814ACA1303986CCA 1303986 CCA1303986 CCA 1303986CCA 486814 CA486814 CA 486814CA 486814 ACA486814 ACA 486814ACA 1303986 CCA1303986 CCA 1303986C
Authority
CA
Canada
Prior art keywords
ifn
cells
interferon
dsrna
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEM Pharmaceuticals Corp
Johns Hopkins University
Original Assignee
HEM Pharmaceuticals Corp
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEM Pharmaceuticals Corp, Johns Hopkins UniversityfiledCriticalHEM Pharmaceuticals Corp
Priority to CA 486814priorityCriticalpatent/CA1303986C/fr
Application grantedgrantedCritical
Publication of CA1303986CpublicationCriticalpatent/CA1303986C/fr
Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2′-β-fluoro-2′, 3′-dideoxyadenosine in peripheral blood mononuclear cells
Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation